Literature DB >> 20728317

Leishmaniasis in the World Health Organization Eastern Mediterranean Region.

Jose A Ruiz Postigo1.   

Abstract

Leishmaniasis represents a major public health problem in the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO). Cutaneous and visceral leishmaniasis are mainly seen in 14 of the 22 countries of the region. In several of these countries outbreaks have an apparent tendency to occur at around 10-year intervals. In 2008, some 100000 new cases of cutaneous leishmaniasis were reported. Foci of zoonotic cutaneous leishmaniasis, caused by Leishmania major, occur in Afghanistan, Egypt, Iran, Iraq, Jordan, Libya, Morocco, Palestine, Pakistan, Saudi Arabia, Sudan, Syria, Tunisia and Yemen. Anthroponotic cutaneous leishmaniasis, caused by L. tropica, occurs in Afghanistan, Iran, Iraq, Morocco, Pakistan, Saudi Arabia, Syria and Yemen. Anthroponotic visceral leishmaniasis, caused by L. donovani, occurs mainly in Sudan and Somalia. Zoonotic visceral leishmaniasis, caused by L. infantum, occurs in most countries of the region. In order to address the problem of leishmaniasis in the EMR, WHO is supporting ministries of health through a strategic plan focusing on (a) training programme managers and health workers on diagnosis and case management; (b) establishing a harmonized regional surveillance system; (c) creating a regional network of experts; (d) promoting political commitment of national governments.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2010        PMID: 20728317     DOI: 10.1016/j.ijantimicag.2010.06.023

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  87 in total

1.  Cutaneous leishmaniasis: an epidemiological study in southwest of Iran.

Authors:  Shahrzad Soltani; Masoud Foroutan; Maryam Hezarian; Hamed Afshari; Mehdi Sagha Kahvaz
Journal:  J Parasit Dis       Date:  2019-01-02

Review 2.  Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis.

Authors:  Sajad Rashidi; Kurosh Kalantar; Gholamreza Hatam
Journal:  J Parasit Dis       Date:  2018-03-19

3.  Knowledge, attitude, and practices related to cutaneous leishmaniasis in an endemic focus of cutaneous leishmaniasis, Southern Iran.

Authors:  Bahador Sarkari; Asgari Qasem; Mohammad Reza Shafaf
Journal:  Asian Pac J Trop Biomed       Date:  2014-07

4.  Post-earthquake outbreak of cutaneous leishmaniasis in a rural region of southern Iran.

Authors:  M R Fakoorziba; A Baseri; F Eghbal; S Rezaee; K Azizi; M D Moemenbellah-Fard
Journal:  Ann Trop Med Parasitol       Date:  2011-04

5.  CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.

Authors:  Hossein Keshavarz Valian; Mahmoud Nateghi Rostami; Minoo Tasbihi; Akram Miramin Mohammadi; Seyed Ebrahim Eskandari; Abdolfattah Sarrafnejad; Ali Khamesipour
Journal:  J Clin Immunol       Date:  2012-09-19       Impact factor: 8.317

6.  The severity of cutaneous leishmaniasis before and after the earthquake in Bam, southeastern Iran.

Authors:  Iraj Sharifi; Mohammad Reza Aflatoonian; Behnaz Aflatoonian; Alireza Kermanizadeh
Journal:  J Parasit Dis       Date:  2014-03-12

7.  Old World cutaneous leishmaniasis: diagnosis and treatment.

Authors:  Abderrahmen Masmoudi; Wala Hariz; Slaheddine Marrekchi; Mariem Amouri; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2013-06-30

Review 8.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

9.  Molecular identification of Leishmania spp. isolates causes cutaneous leishmaniasis (CL) in Sanliurfa Province, Turkey, where CL is highly endemic.

Authors:  Gulcan Gurses; Mehmet Ozaslan; Fadile Yıldız Zeyrek; Ibrahim H Kılıç; Nebiye Yentür Doni; I Didem Karagöz; Nermin Uluca
Journal:  Folia Microbiol (Praha)       Date:  2017-12-07       Impact factor: 2.099

Review 10.  Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.

Authors:  Shyam Sundar; Om Prakash Singh; Jaya Chakravarty
Journal:  Expert Rev Anti Infect Ther       Date:  2018-10-10       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.